Using outcome data from one thousand mosaic embryo transfers to formulate an embryo ranking system for clinical use
Characteristics of mosaicism revealed during preimplantation genetic testing for aneuploidy affect clinical outcomes and can be considered when selecting embryos for intrauterine transfer.
Manuel Viotti, Ph.D., Andrea R. Victor, M.S., Frank L. Barnes, Ph.D., Christo G. Zouves, M.D., Andria G. Besser, M.S., James A. Grifo, M.D., Ph.D., En-Hui Cheng, Ph.D., Maw-Sheng Lee, M.D., Ph.D., Jose A. Horcajadas, Ph.D., Laura Corti, M.Sc., Francesco Fiorentino, Ph.D., Francesca Spinella, Ph.D., Maria Giulia Minasi, M.Sc., Ermanno Greco, M.D., Santiago Munné, Ph.D.
Abstract:
Objective
To study how the attributes of mosaicism identified during preimplantation genetic testing for aneuploidy relate to clinical outcomes, in order to formulate a ranking system of mosaic embryos for intrauterine transfer.
Design
Compiled analysis.
Setting
Multi-center.
Patient(s)
A total of 5,561 euploid blastocysts and 1,000 mosaic blastocysts used in clinical transfers in patients undergoing fertility treatment.
Intervention(s)
None.
Main Outcome Measure(s)
Implantation (gestational sac), ongoing pregnancy, birth, and spontaneous abortion (miscarriage before 20 weeks of gestation).
Result(s)
The euploid group had significantly more favorable rates of implantation and ongoing pregnancy/birth (OP/B) compared with the combined mosaic group or the mosaic group affecting only whole chromosomes (implantation: 57.2% vs. 46.5% vs. 41.8%; OP/B: 52.3% vs. 37.0% vs. 31.3%), as well as lower likelihood of spontaneous abortion (8.6% vs. 20.4% vs. 25%). Whole-chromosome mosaic embryos with level (percent aneuploid cells) <50% had significantly more favorable outcomes than the ≥50% group (implantation: 44.5% vs. 30.4%; OP/B: 36.1% vs. 19.3%). Mosaic type (nature of the aneuploidy implicated in mosaicism) affected outcomes, with a significant correlation between number of affected chromosomes and unfavorable outcomes. This ranged from mosaicism involving segmental abnormalities to complex aneuploidies affecting three or more chromosomes (implantation: 51.6% vs. 30.4%; OP/B: 43.1% vs. 20.8%). Combining mosaic level, type, and embryo morphology revealed the order of subcategories regarding likelihood of positive outcome.
Conclusion(s)
This compiled analysis revealed traits of mosaicism identified with preimplantation genetic testing for aneuploidy that affected outcomes in a statistically significant manner, enabling the formulation of an evidence-based prioritization scheme for mosaic embryos in the clinic.
Did Coopersurgical use PGT-Ai (artificial intelligence) in the interpretation of the results, and would that attribute to the high variability of mosaicism rate in between contributing centers?
Using outcome data from one thousand mosaic embryo transfers to formulate an embryo ranking system for clinical use
Characteristics of mosaicism revealed during preimplantation genetic testing for aneuploidy affect clinical outcomes and can be considered when selecting embryos for intrauterine transfer.
This is a representation of how your post may appear on social media. The actual post will vary between social networks
We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.
You can consent to the use of such technologies by closing this notice.
Cookie Control
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activities described below. To learn more about how these trackers help us
and how they work, refer to the cookie policy. You may review and change your preferences at any time.
These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.
These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.
Comments
Did Coopersurgical use PGT-Ai (artificial intelligence) in the interpretation of the results, and would that attribute to the high variability of mosaicism rate in between contributing centers?